Category : Healthcare and Pharmaceuticals | Published at : February-2021 | Delivery Format : PDF | Status: Published | Pages : 190
The market for antimicrobial susceptibility testing is expected to grow at a CAGR of around 5.4% from 2020 to 2027 and expected to reach the market value of around US$ 4,764.3 Mn by 2027.
Antimicrobial Susceptibility Testing or AST is a laboratory procedure performed by medical technologists particularly to determine which antimicrobials will inhibit the growth of the bacteria or fungi causing a specific infection. The results of this test help practitioners to determine which drug is most effective to treat a person's infection. Additionally, on a large scale, it aids in the evaluation of treatment services provided by the clinics, hospitals, and national programs for the control and prevention of infectious diseases.
Market Dynamics
The rising incidence of infectious diseases across the globe coupled with epidemic & pandemic events like coronavirus are driving the market growth. The increasing research grants, funding, and public-private investments in the healthcare market especially in developing economies are supporting the market growth. The technological advancements associated with the testings and solutions in the healthcare sector are additionally bolstering the market growth. The growing government initiatives to detect and control antimicrobial-resistant species are further boosting the market value. The emergence of multidrug-resistance due to drug abuse is propelling the market value. Furthermore, awareness initiatives for antimicrobial resistance and its control are projected to create potential opportunities over the forecast period from 2020 to 2027.
On the other side, high cost associated with the automated identification (ID) and antibiotic susceptibility test (AST) systems are likely to limit the growth to an extent over the forecast period from 2020 to 2027.
Segment Instance of Global Antimicrobial Susceptibility Testing Market
Antibacterial Susceptibility Testing is leading the market with maximum revenue share
In 2019, antibacterial susceptibility testing segment by type is having potential share in the market and the segment is also projected to maintain its dominance over the forecast period from 2020 to 2027. The rapid investment and advancement in the segment is supporting its growth in the global market.
North America accounted for the maximum share (%) in the antimicrobial susceptibility testing market
In 2019, North America leads the antimicrobial susceptibility testing market with maximum share in terms of revenue, and the region is also anticipated to maintain its dominance over the forecast period from 2020 to 2027. The presence of major players in the region is the primary factor supporting the regional market value. The early adoption and investment in testing practices particularly in the US and Canada are supporting the regional market value. The US market value dominated the North America antimicrobial susceptibility testing market.
Asia Pacific is projected to exhibit fastest growth over the forecast period from 2020 to 2027
The Asia Pacific region is exhibiting the fastest growth during the forecast period on account of its rapidly developing economies including China and India. The developing healthcare sector coupled with the investment in infrastructure development, technology advancement, and an increasing number of professional practices are supporting the regional market growth. The increasing research and development activities in the region are additionally supporting the regional market growth.
Key Market Players
The players profiled in the report include Alifax, Becton Dickinson and Company (BD), Biomerieux, Bio-Rad Laboratories, Inc, Creative Diagnostics, Danaher Corporation, HiMedia Laboratories, Merck KGaA, Resistell AG, Thermo Fisher Scientific Inc, and others.
Market Segmentation
Market By Product
Manual Antimicrobial Susceptibility Testing Products
- Susceptibility Testing Disks
- MIC Strips
- Susceptibility Testing Plates
Automated Laboratory Instruments
Culture and Growth Media
Consumables
Market By Type
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Other Susceptibility Testing Types (slow-growing pathogens)
Market By Application
Clinical Diagnostics
Drug Discovery and Development
Epidemiology
Other
Market By End User
Hospitals and Diagnostic Centers
Pharmaceutical and Biotechnology Companies
Research & Academic Institutes
Clinical Research Organizations (CROs)
Market By Geography
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Frequently Asked Questions
The market for antimicrobial susceptibility testing is expected to reach a market value of around US$ 4,764.3 Mn by 2027.
The antimicrobial susceptibility testing market is expected to grow at a CAGR of around 5.4% from 2020 to 2027.
The antibacterial susceptibility testing is the leading segment by type in the antimicrobial susceptibility testing market
The rising incidence of infectious diseases across the globe, epidemic & pandemic events like corona virus, increasing research grants, funding, and public-private investments, technological advancements associated with the testing and solutions in healthcare sector, and growing government initiatives to detect and control antimicrobial-resistant species are some of the factors driving the market growth.
Alifax, BD, biomerieux, Bio-Rad Laboratories, Inc, Creative Diagnostics, Danaher Corporation, HiMedia Laboratories, Merck KGaA, Resistell AG, Thermo Fisher Scientific Inc, and others are the prominent players in the market.
North America held the highest market share in the antimicrobial susceptibility testing market
Asia Pacific is expected to be the fastest growing market over the forecast period
